These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


406 related items for PubMed ID: 7032789

  • 1. Cerebrovascular disease.
    Warlow CP.
    Clin Haematol; 1981 Jun; 10(2):631-51. PubMed ID: 7032789
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease.
    Genton E.
    Circulation; 1980 Dec; 62(6 Pt 2):V111-21. PubMed ID: 6108166
    [No Abstract] [Full Text] [Related]

  • 5. Platelet and antiplatelet agents in strokes.
    Rodvien R, Mielke CH.
    Stroke; 1978 Dec; 9(4):403-5. PubMed ID: 675751
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Address of the president-elect: the indication for various methods of treatment of occlusive cerebrovascular disease.
    Millikan CH.
    Trans Am Neurol Assoc; 1973 Dec; 98():206-18. PubMed ID: 4784937
    [No Abstract] [Full Text] [Related]

  • 8. Anticoagulant therapy: a critique.
    Gross H, Hasson J, Solomon S.
    Am Fam Physician; 1971 Jun; 3(6):87-91. PubMed ID: 5580625
    [No Abstract] [Full Text] [Related]

  • 9. Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts).
    Genton E, Gent M, Hirsh J, Harker LA.
    N Engl J Med; 1975 Dec 04; 293(23):1174-8. PubMed ID: 1102977
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Use of common antiplatelet drugs for vascular diseases.
    Pagano T, Nair CK, Sketch MH.
    Geriatrics; 1983 Nov 04; 38(11):75-95. PubMed ID: 6605278
    [No Abstract] [Full Text] [Related]

  • 12. [Platelet aggregation inhibiting treatment with aspirin. Biological bases. Application to cerebral vascular accidents].
    Boneu B, Guiraud B, Fernet P.
    Nouv Presse Med; 1972 Mar 25; 1(13):863-8. PubMed ID: 5018460
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Drugs in the treatment of thrombo-embolic disease--part I.
    Bouchier-Hayes D.
    Ir Med J; 1983 Feb 25; 76(2):101-5, 107. PubMed ID: 6601642
    [No Abstract] [Full Text] [Related]

  • 17. Management of thrombotic diseases.
    Douglas AS.
    Semin Hematol; 1971 Apr 25; 8(2):95-139. PubMed ID: 4396057
    [No Abstract] [Full Text] [Related]

  • 18. Treating thromboembolic disease.
    Deykin D, Gurewich V, Harker L, Hirsch J.
    Geriatrics; 1977 Oct 25; 32(10):119-21, 125-8. PubMed ID: 302814
    [No Abstract] [Full Text] [Related]

  • 19. [Cerebrovascular diseases. 6. Anticoagulant treatment].
    Gårde A.
    Lakartidningen; 1969 Oct 01; 66(40):4086-9. PubMed ID: 5384310
    [No Abstract] [Full Text] [Related]

  • 20. Anticoagulation in cerebrovascular disease.
    Butler RB.
    Minn Med; 1971 Dec 01; 54(12):1037-41. PubMed ID: 5122038
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.